论文部分内容阅读
目的 比较中国和日本显性出血性胃癌各相关因素及疗效的差异。方法 总结分析了浙江省人民医院（省医组）和日本福井县立病院（日福组）同１０ 年间显性出血性胃癌的临床资料。结果 两组病例 Ｂｏｒｒｍ ａｎｎ ｓ分型均以Ⅱ、Ⅲ型多见，且日福组Ⅱ型较多而省医组Ⅲ型较多（ Ｐ均＜ ０．０５）；两组分化程度无显著差异（ Ｐ＞ ０．０５）；日福组早期胃癌病例显著高于省医组（ Ｐ＜ ０．００１）。日福组根治性切除率及术后 ５ 年生存率均高于省医组（ Ｐ 均＜ ０．０１）。结论 显性出血性胃癌国内病期较晚；显性出血性胃癌与 Ｂｏｒｒｍ ａｎｎ ｓ 分型密切相关，其早期诊断是提高根治性手术切除率及５ 年生存率的关键。
Objective To compare the differences of related factors and efficacy between dominant gastric cancer in China and Japan. METHODS: Clinical data of patients with dominant hemorrhagic gastric cancer in the same decade as Zhejiang Provincial People’s Hospital (Zhejiang Medical Group) and Fukui Prefecture Hospital (Rifu Group) were analyzed. Results The Borr-manns classification was more common in the two groups. Type II and Type III were more common in the two groups, and there were more Type II and Type III types in the provincial group (P < 0.05). There was no differentiation in the two groups. Significant differences (P> 0.05); Early stage gastric cancer cases in Rifu group was significantly higher than that of provincial doctor group (P<0.001). The radical resection rate and 5-year survival rate in the Rifu group were higher than those in the provincial doctor group (P < 0.01). Conclusions Dominant hemorrhagic gastric cancer is a later stage in domestic disease. The dominant hemorrhagic gastric cancer is closely related to Borrmanns classification. Early diagnosis is the key to improve the radical resection rate and 5-year survival rate.